Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
When to re-challenge with venetoclax
Tam suggests re-challenge is reasonable if relapse occurs beyond two years; earlier relapse implies resistance.
Play episode from 17:51
Transcript
